Latest Neuland Laboratories Ltd. Stories
HYDERABAD, India, Jan.
--Recent FDA Audit is Neuland's Ninth Successful FDA Review; Matched by Record of Positive Regulatory Performance in Europe and Japan-- HYDERABAD, India, Jan.
HYDERABAD, India, Oct.
HYDERABAD, India, Aug.
--Improving Product Mix Fueled 95% Increase in Net Profits Year-Over-Year-- HYDERABAD, India, May 9, 2014 /PRNewswire/ -- Neuland Laboratories Ltd., (NSE:NEULANDLAB; BSE-Scrip Code:524558)
--APIC Investment in Dedicated State-of-the-Art Facility Allows Neuland to Produce Competitively-Priced Pharmaceutical APIs and Intermediates for APIC-- HYDERABAD, India, April 8,
--Strengthening Margins and Continued Deleveraging Contribute to Improved Profitability as Year-Over-Year After-Tax Profits Rise-- HYDERABAD, India, Feb.
- The parings of haberdine; also, any kind of fragments.